@prefix fhir: <http://hl7.org/fhir/> .
@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix rdf: <http://www.w3.org/1999/02/22-rdf-syntax-ns#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

# - resource -------------------------------------------------------------------

<https://interop.esante.gouv.fr/ig/fhir/eclaire/ResearchStudy/2022-500014-26-00-example-v2> a fhir:ResearchStudy ;
  fhir:nodeRole fhir:treeRoot ;
  fhir:id [ fhir:v "2022-500014-26-00-example-v2"] ; # 
  fhir:meta [
     fhir:lastUpdated [ fhir:v "2023-04-12T00:00:00.000Z"^^xsd:dateTime ] ;
     fhir:profile ( [
       fhir:v "https://interop.esante.gouv.fr/ig/fhir/eclaire/StructureDefinition/eclaire-researchstudy"^^xsd:anyURI ;
       fhir:link <https://interop.esante.gouv.fr/ig/fhir/eclaire/StructureDefinition/eclaire-researchstudy>
     ] )
  ] ; # 
  fhir:text [
     fhir:status [ fhir:v "extensions" ] ;
     fhir:div "<div xmlns=\"http://www.w3.org/1999/xhtml\"><p class=\"res-header-id\"><b>Generated Narrative: ResearchStudy 2022-500014-26-00-example-v2</b></p><a name=\"2022-500014-26-00-example-v2\"> </a><a name=\"hc2022-500014-26-00-example-v2\"> </a><a name=\"2022-500014-26-00-example-v2-fr-FR\"> </a><div style=\"display: inline-block; background-color: #d9e0e7; padding: 6px; margin: 4px; border: 1px solid #8da1b4; border-radius: 5px; line-height: 60%\"><p style=\"margin-bottom: 0px\">Last updated: 2023-04-12 00:00:00+0000</p><p style=\"margin-bottom: 0px\">Profil: <a href=\"StructureDefinition-eclaire-researchstudy.html\">ECLAIREResearchStudy</a></p></div><p><b>ECLAIREReviewDate</b>: 2023-04-12 00:00:00+0000</p><p><b>ECLAIRETherapeuticArea</b>: [Traduction locale] Diseases [C] - Neoplasms [C04]</p><p><b>ECLAIRERecruitmentPeriod</b>: 2022-06-30 00:00:00+0000 --&gt; (ongoing)</p><blockquote><p><b>ECLAIREassociatedPartyR5</b></p><ul><li>name: F. Hoffmann-La Roche AG</li><li>role: <span title=\"Codes:{https://interop.esante.gouv.fr/ig/fhir/eclaire/CodeSystem/eclaire-study-party-role-code-system lead-sponsor}\">lead-sponsor</span></li><li>party: <a href=\"Organization/2022-500014-26-00-primary-sponsor\">Reference to primary sponsor</a></li></ul></blockquote><p><b>identifier</b>: 2022-500014-26-00 (use: official, )</p><p><b>title</b>: [Traduction locale] A PHASE III, RANDOMIZED, OPEN-LABEL STUDY EVALUATING THE EFFICACY AND SAFETY OF GIREDESTRANT IN COMBINATION WITH PHESGO VERSUS PHESGO AFTER INDUCTION THERAPY WITH PHESGO+TAXANE IN PATIENTS WITH PREVIOUSLY UNTREATED HER2-POSITIVE, ESTROGEN RECEPTOR-POSITIVE LOCALLY-ADVANCED OR METASTATIC BREAST CANCER</p><p><b>status</b>: Active</p><p><b>phase</b>: <span title=\"Codes:{http://terminology.hl7.org/CodeSystem/research-study-phase phase-3}\">Phase 3</span></p><p><b>category</b>: <span title=\"Codes:{https://interop.esante.gouv.fr/ig/fhir/eclaire/CodeSystem/eclaire-regulation-code-code-system REG536}\">REG536 (CTIS)</span>, <span title=\"Codes:{https://interop.esante.gouv.fr/ig/fhir/eclaire/CodeSystem/eclaire-reglementation-precision-code-system study-ctis}\">un essai clinique (CTIS)</span></p><p><b>condition</b>: <span title=\"Codes:\">[Traduction locale] Locally-Advanced or Metastatic breast cancer (MBC)</span>, <span title=\"Codes:{https://www.meddra.org 10070575}\">Cancer du sein à récepteurs aux oestrogènes positifs</span>, <span title=\"Codes:{https://www.meddra.org 10065430}\">Cancer du sein HER2 positif</span></p><p><b>contact</b>: ph: 0041616881111(Work),<a href=\"mailto:global.rochegenentechtrials@roche.com\">global.rochegenentechtrials@roche.com</a>, ph: -unknown-(Work),<a href=\"mailto:null\"/></p><p><b>location</b>: <span title=\"Codes:{urn:iso:std:iso:3166 BE}\">Belgium</span>, <span title=\"Codes:{urn:iso:std:iso:3166 DE}\">Germany</span>, <span title=\"Codes:{urn:iso:std:iso:3166 ES}\">Spain</span>, <span title=\"Codes:{urn:iso:std:iso:3166 FR}\">France</span>, <span title=\"Codes:{urn:iso:std:iso:3166 HU}\">Hungary</span>, <span title=\"Codes:{urn:iso:std:iso:3166 IT}\">Italy</span>, <span title=\"Codes:{urn:iso:std:iso:3166 PL}\">Poland</span>, <span title=\"Codes:{urn:iso:std:iso:3166 PT}\">Portugal</span></p><p><b>enrollment</b>: <a href=\"Group/2022-500014-26-00-enrollment-group\">Reference to group detailing study characteristics</a></p><p><b>site</b>: <a href=\"Location/2022-500014-26-00-0-site\">Reference to site</a></p></div>"^^rdf:XMLLiteral
  ] ; # 
  fhir:extension ( [
     fhir:url [ fhir:v "https://interop.esante.gouv.fr/ig/fhir/eclaire/StructureDefinition/eclaire-review-date"^^xsd:anyURI ] ;
     fhir:value [
       a fhir:instant ;
       fhir:v "2023-04-12T00:00:00.000Z"^^xsd:dateTime
     ]
  ] [
     fhir:url [ fhir:v "https://interop.esante.gouv.fr/ig/fhir/eclaire/StructureDefinition/eclaire-therapeutic-area"^^xsd:anyURI ] ;
     fhir:value [
       a fhir:string ;
       fhir:v "[Traduction locale] Diseases [C] - Neoplasms [C04]"
     ]
  ] [
     fhir:url [ fhir:v "https://interop.esante.gouv.fr/ig/fhir/eclaire/StructureDefinition/eclaire-recruitment-period"^^xsd:anyURI ] ;
     fhir:value [
       a fhir:Period ;
       fhir:start [ fhir:v "2022-06-30T00:00:00.000Z"^^xsd:dateTime ]
     ]
  ] [
     fhir:url [ fhir:v "http://hl7.org/fhir/5.0/StructureDefinition/extension-ResearchStudy.descriptionSummary"^^xsd:anyURI ]
  ] [
     fhir:extension ( [
       fhir:url [ fhir:v "name"^^xsd:anyURI ] ;
       fhir:value [
         a fhir:string ;
         fhir:v "F. Hoffmann-La Roche AG"
       ]
     ] [
       fhir:url [ fhir:v "role"^^xsd:anyURI ] ;
       fhir:value [
         a fhir:CodeableConcept ;
         fhir:coding ( [
           fhir:system [ fhir:v "https://interop.esante.gouv.fr/ig/fhir/eclaire/CodeSystem/eclaire-study-party-role-code-system"^^xsd:anyURI ] ;
           fhir:version [ fhir:v "0.3.0" ] ;
           fhir:code [ fhir:v "lead-sponsor" ] ;
           fhir:display [ fhir:v "lead-sponsor" ]
         ] )
       ]
     ] [
       fhir:url [ fhir:v "party"^^xsd:anyURI ] ;
       fhir:value [
         a fhir:Reference ;
         fhir:link <https://interop.esante.gouv.fr/ig/fhir/eclaire/Organization/2022-500014-26-00-primary-sponsor> ;
         fhir:reference [ fhir:v "Organization/2022-500014-26-00-primary-sponsor" ] ;
         fhir:type [ fhir:v "Organization"^^xsd:anyURI ] ;
         fhir:display [ fhir:v "Reference to primary sponsor" ]
       ]
     ] ) ;
     fhir:url [ fhir:v "http://hl7.org/fhir/5.0/StructureDefinition/extension-ResearchStudy.associatedParty"^^xsd:anyURI ]
  ] ) ; # 
  fhir:identifier ( [
     fhir:use [ fhir:v "official" ] ;
     fhir:value [ fhir:v "2022-500014-26-00" ] ;
     fhir:assigner [
       fhir:link <https://interop.esante.gouv.fr/ig/fhir/eclaire/Organization/ctis> ;
       fhir:reference [ fhir:v "Organization/ctis" ] ;
       fhir:type [ fhir:v "Organization"^^xsd:anyURI ] ;
       fhir:display [ fhir:v "Reference to primary assigner" ]
     ]
  ] ) ; # 
  fhir:title [ fhir:v "[Traduction locale] A PHASE III, RANDOMIZED, OPEN-LABEL STUDY EVALUATING THE EFFICACY AND SAFETY OF GIREDESTRANT IN COMBINATION WITH PHESGO VERSUS PHESGO AFTER INDUCTION THERAPY WITH PHESGO+TAXANE IN PATIENTS WITH PREVIOUSLY UNTREATED HER2-POSITIVE, ESTROGEN RECEPTOR-POSITIVE LOCALLY-ADVANCED OR METASTATIC BREAST CANCER"] ; # 
  fhir:status [ fhir:v "active"] ; # 
  fhir:phase [
     fhir:coding ( [
       fhir:system [ fhir:v "http://terminology.hl7.org/CodeSystem/research-study-phase"^^xsd:anyURI ] ;
       fhir:code [ fhir:v "phase-3" ] ;
       fhir:display [ fhir:v "Phase 3" ]
     ] )
  ] ; # 
  fhir:category ( [
     fhir:coding ( [
       fhir:system [ fhir:v "https://interop.esante.gouv.fr/ig/fhir/eclaire/CodeSystem/eclaire-regulation-code-code-system"^^xsd:anyURI ] ;
       fhir:version [ fhir:v "0.3.0" ] ;
       fhir:code [ fhir:v "REG536" ] ;
       fhir:display [ fhir:v "REG536 (CTIS)" ]
     ] )
  ] [
     fhir:coding ( [
       fhir:system [ fhir:v "https://interop.esante.gouv.fr/ig/fhir/eclaire/CodeSystem/eclaire-reglementation-precision-code-system"^^xsd:anyURI ] ;
       fhir:version [ fhir:v "0.3.0" ] ;
       fhir:code [ fhir:v "study-ctis" ] ;
       fhir:display [ fhir:v "un essai clinique (CTIS)" ]
     ] )
  ] ) ; # 
  fhir:condition ( [
     fhir:id [ fhir:v "disease-condition-2022-500014-26-00" ] ;
     fhir:text [ fhir:v "[Traduction locale] Locally-Advanced or Metastatic breast cancer (MBC)" ]
  ] [
     fhir:id [ fhir:v "meddra-condition-2022-500014-26-00-10070575" ] ;
     fhir:coding ( [
       fhir:system [ fhir:v "https://www.meddra.org"^^xsd:anyURI ] ;
       fhir:version [ fhir:v "3.0.0" ] ;
       fhir:code [ fhir:v "10070575" ] ;
       fhir:display [ fhir:v "Cancer du sein à récepteurs aux oestrogènes positifs" ]
     ] )
  ] [
     fhir:id [ fhir:v "meddra-condition-2022-500014-26-00-10065430" ] ;
     fhir:coding ( [
       fhir:system [ fhir:v "https://www.meddra.org"^^xsd:anyURI ] ;
       fhir:version [ fhir:v "3.0.0" ] ;
       fhir:code [ fhir:v "10065430" ] ;
       fhir:display [ fhir:v "Cancer du sein HER2 positif" ]
     ] )
  ] ) ; # 
  fhir:contact ( [
     fhir:extension ( [
       fhir:url [ fhir:v "https://interop.esante.gouv.fr/ig/fhir/eclaire/StructureDefinition/eclaire-contact-name"^^xsd:anyURI ] ;
       fhir:value [
         a fhir:HumanName ;
         fhir:use [ fhir:v "official" ] ;
         fhir:family [ fhir:v "Trial Information Support Line-TISL, Switzerland" ] ;
         fhir:given ( [ fhir:v "Head of EU" ] )
       ]
     ] ) ;
     fhir:telecom ( [
       fhir:system [ fhir:v "phone" ] ;
       fhir:value [ fhir:v "0041616881111" ] ;
       fhir:use [ fhir:v "work" ]
     ] [
       fhir:system [ fhir:v "email" ] ;
       fhir:value [ fhir:v "global.rochegenentechtrials@roche.com" ] ;
       fhir:use [ fhir:v "work" ]
     ] )
  ] [
     fhir:extension ( [
       fhir:url [ fhir:v "https://interop.esante.gouv.fr/ig/fhir/eclaire/StructureDefinition/eclaire-contact-name"^^xsd:anyURI ] ;
       fhir:value [
         a fhir:HumanName ;
         fhir:use [ fhir:v "official" ]
       ]
     ] [
       fhir:url [ fhir:v "https://interop.esante.gouv.fr/ig/fhir/eclaire/StructureDefinition/eclaire-contact-type"^^xsd:anyURI ] ;
       fhir:value [
         a fhir:CodeableConcept ;
         fhir:coding ( [
           fhir:system [ fhir:v "https://interop.esante.gouv.fr/ig/fhir/eclaire/CodeSystem/eclaire-type-contact-code-system"^^xsd:anyURI ] ;
           fhir:version [ fhir:v "0.3.0" ] ;
           fhir:code [ fhir:v "PUB" ] ;
           fhir:display [ fhir:v "Publique / Public" ]
         ] )
       ]
     ] ) ;
     fhir:telecom ( [
       fhir:system [ fhir:v "phone" ] ;
       fhir:use [ fhir:v "work" ]
     ] [
       fhir:system [ fhir:v "email" ] ;
       fhir:use [ fhir:v "work" ]
     ] )
  ] ) ; # 
  fhir:location ( [
     fhir:coding ( [
       fhir:system [ fhir:v "urn:iso:std:iso:3166"^^xsd:anyURI ] ;
       fhir:version [ fhir:v "4.0.1" ] ;
       fhir:code [ fhir:v "BE" ] ;
       fhir:display [ fhir:v "Belgium" ]
     ] )
  ] [
     fhir:coding ( [
       fhir:system [ fhir:v "urn:iso:std:iso:3166"^^xsd:anyURI ] ;
       fhir:version [ fhir:v "4.0.1" ] ;
       fhir:code [ fhir:v "DE" ] ;
       fhir:display [ fhir:v "Germany" ]
     ] )
  ] [
     fhir:coding ( [
       fhir:system [ fhir:v "urn:iso:std:iso:3166"^^xsd:anyURI ] ;
       fhir:version [ fhir:v "4.0.1" ] ;
       fhir:code [ fhir:v "ES" ] ;
       fhir:display [ fhir:v "Spain" ]
     ] )
  ] [
     fhir:coding ( [
       fhir:system [ fhir:v "urn:iso:std:iso:3166"^^xsd:anyURI ] ;
       fhir:version [ fhir:v "4.0.1" ] ;
       fhir:code [ fhir:v "FR" ] ;
       fhir:display [ fhir:v "France" ]
     ] )
  ] [
     fhir:coding ( [
       fhir:system [ fhir:v "urn:iso:std:iso:3166"^^xsd:anyURI ] ;
       fhir:version [ fhir:v "4.0.1" ] ;
       fhir:code [ fhir:v "HU" ] ;
       fhir:display [ fhir:v "Hungary" ]
     ] )
  ] [
     fhir:coding ( [
       fhir:system [ fhir:v "urn:iso:std:iso:3166"^^xsd:anyURI ] ;
       fhir:version [ fhir:v "4.0.1" ] ;
       fhir:code [ fhir:v "IT" ] ;
       fhir:display [ fhir:v "Italy" ]
     ] )
  ] [
     fhir:coding ( [
       fhir:system [ fhir:v "urn:iso:std:iso:3166"^^xsd:anyURI ] ;
       fhir:version [ fhir:v "4.0.1" ] ;
       fhir:code [ fhir:v "PL" ] ;
       fhir:display [ fhir:v "Poland" ]
     ] )
  ] [
     fhir:coding ( [
       fhir:system [ fhir:v "urn:iso:std:iso:3166"^^xsd:anyURI ] ;
       fhir:version [ fhir:v "4.0.1" ] ;
       fhir:code [ fhir:v "PT" ] ;
       fhir:display [ fhir:v "Portugal" ]
     ] )
  ] ) ; # 
  fhir:enrollment ( [
     fhir:link <https://interop.esante.gouv.fr/ig/fhir/eclaire/Group/2022-500014-26-00-enrollment-group> ;
     fhir:reference [ fhir:v "Group/2022-500014-26-00-enrollment-group" ] ;
     fhir:type [ fhir:v "Group"^^xsd:anyURI ] ;
     fhir:display [ fhir:v "Reference to group detailing study characteristics" ]
  ] ) ; # 
  fhir:site ( [
     fhir:link <https://interop.esante.gouv.fr/ig/fhir/eclaire/Location/2022-500014-26-00-0-site> ;
     fhir:reference [ fhir:v "Location/2022-500014-26-00-0-site" ] ;
     fhir:type [ fhir:v "Location"^^xsd:anyURI ] ;
     fhir:display [ fhir:v "Reference to site" ]
  ] ) . # 

# -------------------------------------------------------------------------------------

